Clinical evaluation of teriparatid treatment for osteogenesis imperfecta (Medical News Today, 29 January 2014)

30 Jan 2014


A study in Journal of Clinical Investigation evaluates the use of the teriparatide, a recombinant human parathyroid hormone, for adult patients with osteogenesis imperfecta.

Full article


Related Topics

Bone

Share this story